| Download | - View final version: Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis (PDF, 2.4 MiB)
|
|---|
| DOI | Resolve DOI: https://doi.org/10.1007/s11306-021-01864-6 |
|---|
| Author | Search for: Dahn, Margaret L.; Search for: Walsh, Hayley R.; Search for: Dean, Cheryl A.; Search for: Giacomantonio, Michael A.; Search for: Fernando, Wasundara; Search for: Murphy, J Patrick; Search for: Walker, Olivia L.; Search for: Wasson, Marie-Claire D.; Search for: Gujar, Shashi; Search for: Pinto, Devanand M.1; Search for: Marcato, PaolaORCID identifier: https://orcid.org/0000-0001-8619-283X |
|---|
| Affiliation | - National Research Council of Canada. Human Health Therapeutics
|
|---|
| Format | Text, Article |
|---|
| Abstract | Introduction: Aldehyde dehydrogenase 1A3 (ALDH1A3) is a cancer stem cell (CSC) marker and in breast cancer it is associated with triple-negative/basal-like subtypes and aggressive disease. Studies on the mechanisms of ALDH1A3 in cancer have primarily focused on gene expression changes induced by the enzyme; however, its effects on metabolism have thus far been unstudied and may reveal novel mechanisms of pathogenesis. Objective: Determine how ALDH1A3 alters the metabolite profile in breast cancer cells and assess potential impacts. Method: Triple-negative MDA-MB-231 tumors and cells with manipulated ALDH1A3 levels were assessed by HPLC–MS metabolomics and metabolite data was integrated with transcriptome data. Mice harboring MDA-MB-231 tumors with or without altered ALDH1A3 expression were treated with γ-aminobutyric acid (GABA) or placebo. Effects on tumor growth, and lungs and brain metastasis were quantified by staining of fixed thin sections and quantitative PCR. Breast cancer patient datasets from TCGA, METABRIC and GEO were used to assess the co-expression of GABA pathway genes with ALDH1A3. Results: Integrated metabolomic and transcriptome data identified GABA metabolism as a primary dysregulated pathway in ALDH1A3 expressing breast tumors. Both ALDH1A3 and GABA treatment enhanced metastasis. Patient dataset analyses revealed expression association between ALDH1A3 and GABA pathway genes and corresponding increased risk of metastasis. Conclusion: This study revealed a novel pathway affected by ALDH1A3, GABA metabolism. Like ALDH1A3 expression, GABA treatment promotes metastasis. Given the clinical use of GABA mimics to relieve chemotherapy-induced peripheral nerve pain, further study of the effects of GABA in breast cancer progression is warranted. |
|---|
| Publication date | 2022-01 |
|---|
| Publisher | Springer Nature |
|---|
| Licence | |
|---|
| In | |
|---|
| Language | English |
|---|
| Peer reviewed | Yes |
|---|
| Identifier | 1864 |
|---|
| Export citation | Export as RIS |
|---|
| Report a correction | Report a correction (opens in a new tab) |
|---|
| Record identifier | 89b982d5-662c-4f89-8c52-a6de98311275 |
|---|
| Record created | 2024-02-27 |
|---|
| Record modified | 2024-02-27 |
|---|
